Congestive Heart Failure - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

文章摘要

Heart Failure With Improved Ejection Fraction-Is it Possible to Escape One’s Past?
Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure
Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
3D Printing and Heart Failure: The Present and the Future
Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification
Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk Estimates
Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction
Ejection Fraction Pros and Cons: JACC State-of-the-Art Review
In acute HF and iron deficiency, IV ferric carboxymaltose reduced HF hospitalizations, but not CV death, at 1 y

Clinical Trial

2017 Aug 22;318(8):713-720.

JOURNAL：JAMA.

Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial

Felker GM, Anstrom KJ1, Adams KF et al.

3628

Keywords: Natriuretic Peptide–Guided Therapy; RCT; usual care; Hospitalization; Cardiovascular Mortality ; Heart Failure and Reduced Ejection Fraction

FULL TEXT PDF